No Data
No Data
Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Morgan Stanley Identifies 39 Stocks Likely to Face Tax Loss Selling Pressure
Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3
Gilead Signs Deals With Six Drugmakers for Generic Lenacapavir
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today